Revolutions in gene therapy are rapidly changing the landscape of modern medicine, forcing society and science alike to ...

Drug development in biotechnology takes time. A lot of time. On average, it takes 10 to 15 years to take a medicine from ...

The FDA has granted approval to a new gene therapy for a rare immune disorder, the maker of which is notably not a drug ...

The human genome is driving healthcare innovation, and the biopharmaceutical industry is increasingly focusing research and development centered on understanding the role of genetics in health and ...

Trailblazing geneticist Pengfei Liu, Ph.D., Associate Professor in the Department of Molecular and Human Genetics at Baylor ...

Genetic engineering is moving from the lab bench into clinics, farms, and even family planning decisions, promising to change ...

An international collective of researchers is delivering new insights into why having multiple psychiatric disorders is the ...

From rare diseases to chronic conditions, epigenetic editing unlocks new ways to control gene activity without altering the genetic code.

After more than 50 years of research, scientists still don't know exactly what causes autism. But the data make clear that ...

A new University of California San Diego School of Medicine study offers a unified biological model to explain how genetic ...

The critical work of those racing to cure rare pediatric diseases got an important shot in the arm today. Florida’s newly created Sunshine Genetics Consortium promises hope for children living with ...

A new study proposes that autism arises when genetic vulnerability, an early environmental trigger, and prolonged activation of the cellular stress response align during critical developmental windows ...